Skip to main content
. 2017 Mar 8;15(3):e04698. doi: 10.2903/j.efsa.2017.4698

Table 4.

Observed prevalence derived from the EU Member States’ monitoring and surveillance data (only those data with a prevalence > 0 are included)

3.3.1.